← Leaderboards
Jose Javier Bravo-Cordero
Icahn School Of Medicine At Mount Sinai
$4,544,873
Attributed
$4,544,873
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,544,873 · 6
By mechanism
R01$1,903,762 · 1
P01$1,175,638 · 2
R61$706,405 · 1
K22$576,720 · 1
R03$182,348 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Kurt William Farrell$693,763
- Cheng Zhang$6,068,855
- Eric A Sobie$19,661,319
- Alex D. Federman$23,066,128
- Juan P Wisnivesky$34,328,417
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularIn VivoCellsInnovationMalignant NeoplasmsOrganTumorNeoplasm MetastasisCancer CellHigh Resolution ImagingNeoplastic CellIntravital ImagingBiologyResearch DesignResolutionPrimary NeoplasmProteinsMouse ModelAftercareCessation Of LifeBrainLiverBlood VesselsExtracellular Matrix
Grant awards (18)
Intersectional genetics-based biosensors for dormant cancer cells$213,638
R61 · FY2025 · CA · contact PI
Defining the role of type III collagen and the collagen-binding receptor DDR1 in metastatic dormancy$368,346
R01 · FY2024 · CA · contact PI
Core B - Advance Imaging Core$293,911
P01 · FY2024 · AG · contact PI
Intersectional genetics-based biosensors for dormant cancer cells$190,495
R61 · FY2024 · CA · contact PI
Defining the role of type III collagen and the collagen-binding receptor DDR1 in metastatic dormancy$379,977
R01 · FY2023 · CA · contact PI
Core B - Advance Imaging Core$293,909
P01 · FY2023 · AG · contact PI
Intersectional genetics-based biosensors for dormant cancer cells$217,772
R61 · FY2023 · CA · contact PI
IMAT-ITCR Collaboration: Artificial intelligence enhanced breast cancer dormancy cell classification-based organelle-morphology and topology$84,500
R61 · FY2023 · CA · contact PI
Recording the natural history of cancer progression using a Crainbow model of HER2+ cancer$82,552
R03 · FY2023 · CA · contact PI
Defining the role of type III collagen and the collagen-binding receptor DDR1 in metastatic dormancy$379,977
R01 · FY2022 · CA · contact PI
Core B - Advance Imaging Core$293,909
P01 · FY2022 · AG · contact PI
Recording the natural history of cancer progression using a Crainbow model of HER2+ cancer$99,796
R03 · FY2022 · CA · contact PI
Defining the role of type III collagen and the collagen-binding receptor DDR1 in metastatic dormancy$387,731
R01 · FY2021 · CA · contact PI
Core B - Advance Imaging Core$293,909
P01 · FY2021 · AG · contact PI
Defining the role of type III collagen and the collagen-binding receptor DDR1 in metastatic dormancy$387,731
R01 · FY2020 · CA · contact PI
Protrusion plasticity during in vivo tumor cell migration$192,240
K22 · FY2018 · CA · contact PI
Protrusion plasticity during in vivo tumor cell migration$192,240
K22 · FY2017 · CA · contact PI
Protrusion plasticity during in vivo tumor cell migration$192,240
K22 · FY2016 · CA · contact PI